Fosun Pharmaceutical bought Concert Pharmaceuticals Concert Pharmaceuticals from 1/19/23

User image

Vladimir Petenev

News editor
press@blackterminal.com

Fosun Pharmaceutical bought Concert Pharmaceuticals for $576 million, or $8 per share.

Concert Pharmaceuticals

Review

Source:

{source} pictogram

ir.concertpharma.com

Vladimir Petenev

News editor

Write your comment first

News feed

Ozon Bank to launch credit cards for individuals

2/27/25 OZON

brainbox collected all the stratape broadcasts in one bot

2/27/25 OTCI

Sberbank is ready to pay dividends

2/27/25 SBER

Rusal will set up pilot production of scandium oxide

2/27/25 RUAL

Fix Price's LFL sales in 2024 grew by 1.5%

2/27/25 FIXP

Fix Price reported for 2024 by IFRS

2/27/25 FIXP

Ozon's turnover in 2024 grew by 64%

2/27/25 OZON

Sberbank reports for 2024 by IFRS

2/27/25 SBER

Ozon reported for 2024 by IFRS

2/27/25 OZON

Yandex allocates unmanned transportation into an independent business direction

2/27/25 YDEX